Rare diseases
Investigational molecules
Locations
Back to France2 221 clinical trials in Lyon, France across 7 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Durvalumab and Tremelimumab for Patients with Kidney Cancer at Risk of Recurrence After Surgery
FranceStudy on Rituximab and Cyclophosphamide for Patients with Severe Mucous Membrane Pemphigoid
FranceStudy of PF-07220060 and Letrozole for Postmenopausal Women with HR-Positive, HER2-Negative Breast Cancer
FranceLong-term safety and efficacy study of elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis who have non-F508del genetic mutations
FranceStudy on the Effectiveness of Nivolumab, Ipilimumab, and Pazopanib in Patients with Advanced Rare Sarcomas
FranceStudy on Isatuximab, Lenalidomide, and Dexamethasone for Elderly Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant
FranceStudy of ASTX727 and Donor Lymphocyte Infusions for Patients with High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia After Stem Cell Transplant
FranceStudy of Durvalumab, Olaparib, and Fulvestrant for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer with Specific Genetic Alterations
FranceStudy of INBRX-109 (ozekibart) compared to placebo in adults with unresectable or metastatic chondrosarcoma - a rare bone cancer
FranceStudy on Durvalumab and Tremelimumab for Liver Cancer Patients Undergoing Electroporation Ablation
FranceStudy on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
FranceStudy on the Safety and Effectiveness of Luveltamab Tazevibulin (STRO-002) for Infants and Children Under 12 with Acute Myeloid Leukemia (AML)
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, including studies for endometrial carcinoma, bladder cancer, and various solid tumors. Current research explores combination therapies with novel immunotherapy approaches.
Multiple studies are evaluating targeted therapies and immunological approaches for various tumor types.
Groundbreaking research in immune system modulation and infectious disease prevention, including studies on COVID-19 vaccines and immune response in critical conditions.
Focus on developing innovative vaccination strategies and immune system interventions.
Studies addressing long-term health conditions, with particular emphasis on kidney disease, cardiovascular health, and metabolic disorders.
Innovative approaches combining established and experimental treatments for improved patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
